English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 29490/55136 (53%)
造訪人次 : 1505113      線上人數 : 280
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    主頁登入上傳說明關於CMUR管理 到手機版
    請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/950


    題名: 斑蝥素對COLO 205 結腸直腸癌細胞株生長抑制作用與抗癌分子機制之探討;Study of the cantharidin on anti-proliferation and anti-cancer molecular mechanisms in COLO 205 cells
    作者: 柯世薇;Shih-Wei Ko
    貢獻者: 中國醫藥大學:藥學系
    關鍵詞: 斑蝥素;蛋白質磷酸化酶;抑制劑;生長抑制;抗癌;結腸直腸癌;cantharidin;PP 1 inhibitor;PP 2A inhibitor;anti-proliferation;anti-cancer;coloretal cancer
    日期: 2008-07-04
    上傳時間: 2009-08-13 10:53:56 (UTC+8)
    摘要: 近26年來,癌症一直為十大死因之首,目前尚無良好的對策來治療癌症。結腸直腸癌是常見且致死的癌症,在美國是癌症致死居第二位,於台灣癌症十大死因居第三位。臨床治療上以外科手術、化學治療及放射線治療為主。但治療之效果與預後都不盡理想,因此研發有效且副作用小的的抗癌藥物為當務之急,利用藥物誘發癌細胞凋亡,此為生物體維持體內平衡的機制之一。且發生凋亡時並不會引起發炎反應,對人體副作用較小,因此誘發細胞凋亡是目前抗癌治療策略及抗癌藥物發展的重要方向。
    斑蝥素 (Cantharidin)是斑蝥主要藥用成份,相關研究證實Cantharidin具有抗癌、免疫調節、抗菌與抗病毒等作用。本論文主要研究目的,在探討Cantharidin對結腸直腸癌細胞株 (COLO 205)生長抑制作用與抗癌機制。
    我們以倒立式相位差顯微鏡檢測細胞型態變化,顯示經Cantharidin處理後細胞數有變少及皺縮的情形,且有似凋亡小體產生。以MTT方法檢測細胞存活率,實驗結果顯示COLO 205細胞經Cantharidin處理後,細胞存活率呈現劑量與時間依存性的抑制,其IC50為 20.53?嵱。 細胞週期分析顯示Cantharidin誘導COLO 205細胞停滯於G2/M 期後,進而誘導細胞凋亡。以西方點墨法與CDK1活性檢測結果顯示,Cantharidin會降低cyclin B,CDK1蛋白質的表現和活性,並促使ChkI及 p21等蛋白質量增加。
    利用TUNEL、DAPI及Annexin-V染色及流式細胞儀檢測結果顯示有細胞凋亡的現象。檢測細胞粒線體膜電位及超氧自由基,顯示粒線體膜電位降低及超氧自由基(ROS)增加,以西方點墨法及caspase 活性檢測顯示cytochrome c、Fas、Bax和Bad表現量增加,Bcl-2蛋白質表現量降低,caspase-3、-8及-9活性增加,以Real time PCR檢測AIF、Caspase-3、-8及-9 mRNA量有明顯增加。
    綜合以上結果,我們推論Cantharidin具有抑制細胞週期進行與活化粒腺體路徑和死亡受體接受體路徑而誘導細胞凋亡。

    The past 26 years, the cancer has been the first of ten major causes of the death all the time, and good countermeasure does not treat the cancer yet. Colorectal cancer (CRC) is a common and lethal malignant disease, it’s the second most frequent cause of cancer-related death in the United States and occupy the third place in ten major causes of the death of the cancer in Taiwan. Surgical resection、chemotherapy and radiotherapy is the major treatment modality for CRC, but therapeutical effect and prognosis are not perfect. Therefore, investigate an effective and fewer side effect anticancer druge is the task of top priority. Apoptosis is one of the organism maintains the balanced and will not cause inflammation, it has fewer side effect for humen body. Therefore the most important strategy of chemotherapy is utilize medicine to induce cancer cell apoptosis.
    Cantharidin is the extract of the blister beetle, Mylabris, has been demonstrated to possess antitumor、Immune adjustment、antibiotic and antivirus effect. This thesis main research purpose to probe into that cantharidin can inhibit grow and anticancer mechanism for colorectal cell line (COLO 205).
    We use the microscope detects the change of cell type and showing that COLO 205 cell line deal with cantharidin, reduce the cell number、shrink and look like has apoptosome. The MTT assay show that COLO 205 cell line deal with cantharidin, cell survival rate show a dose- and time-dependent manner, IC50 is 20.53μM. Cell cycle analyze show cantharidin induced COLO 205 cell line that cell cycle arrest at G2/M phase then induce apoptosis. Western blot and CDK1 activity show cantharidin can reduce cyclin B and CDK1 activity, and can promote chk1 and p21.
    The TUNEL、DAPI and annexin-v assay is to display the apoptosis of cantharidin on COLO 205. The MMP and ROS assay show reduce the mitochondria membrane potential and increase reactive oxygen species. Western blot and caspase activity assay demonstrate that cytochrome c、Bax、Bad and Fas are increase, Bcl-2 is decrease,and promote caspase-3、-8 and -9 activity.
    Comprehensive the above result, cantharidin can inhibited cell cycle and activity mitochodria/stress pathway、death receptor pathway then induced cell apoptosis.
    顯示於類別:[藥學系暨碩博士班] 博碩士論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    cmu-97-9471303-1.pdf2241KbAdobe PDF740檢視/開啟
    index.html0KbHTML8檢視/開啟


    在CMUR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

     


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋